Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-5.55%Free Cash Flow Margin
VS
Market
Sector
Industry
History
$ 1.86Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information
Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTPROTALIX BIOTHERAPEUTICS INC - Free Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PLX - FCF % Historical data
| Date | Free Cash Flow | Free Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -3.44M | -5.55% | $ 61.95M |
| 3/31/2025 | $ -1.56M | -2.61% | $ 59.76M |
| 12/31/2024 | $ 7.39M | 13.85% | $ 53.4M |
| 9/30/2024 | $ 7.17M | 15.71% | $ 45.67M |
| 6/30/2024 | $ -4.18M | -10.99% | $ 38.05M |
| 3/31/2024 | $ 4.37M | 7.32% | $ 59.65M |
| 12/31/2023 | $ -2.47M | -3.77% | $ 65.49M |
| 9/30/2023 | $ -8.64M | -13.57% | $ 63.63M |
| 6/30/2023 | $ -10.56M | -15.66% | $ 67.46M |
| 3/31/2023 | $ -22.82M | -55.46% | $ 41.14M |
Key Performance Insights, Last 5 Years
- PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) FCF % stands at -37.03%.
- Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average FCF % has been -23.79%.
- The median FCF % for PROTALIX BIOTHERAPEUTICS INC during this period was -22.97%
- PROTALIX BIOTHERAPEUTICS INC reached its highest FCF % over the past 5 years at 15.71%.
- The lowest FCF % recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe -59.57%
PROTALIX BIOTHERAPEUTICS INC's FCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF % Benchmarks
Similar metrics to Revenues:
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Free Cash Flow Margin
[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.FCF / Revenues
(=) FCF % FCF % for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: FCF [ $ -22.65M ] / Revenues [ $ 61.16M ]
(=) FCF % [ -37.03% ] PLX - Free Cash Flow Margin, Last 5 years
-59.57%
Minimum
Sep 30, 2022
15.71%
Maximum
Sep 30, 2024
-23.79%
Average
-22.97%
Median
FCF % Benchmark AnalysisMarket
The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | -58.23% |
| max | 68.19% |
| average | 7.85% |
| median | 7.37% |
| std | 19.48% |